Acumen Pharmaceuticals, Inc. Basic Shares Outstanding (Weighted Average)
Acumen Pharmaceuticals, Inc. (ABOS) reported Basic Shares Outstanding (Weighted Average) of 72.25 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-12
- Acumen Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 72.25M shares, a 19.28% increase year-over-year.
- Acumen Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 63.22M shares, a 4.45% increase year-over-year.
- Acumen Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 60.57M shares, a 0.82% increase year-over-year.
- Acumen Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 60.57M shares, a 0.82% increase year-over-year.
- Acumen Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 60.56M shares, a 0.91% increase from fiscal 2024.
- Acumen Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 60.01M shares, a 23.46% increase from fiscal 2023.
- Acumen Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 48.61M shares, a 19.72% increase from fiscal 2022.
- Acumen Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 40.60M shares, a 102.43% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 72.25M shares 10-Q · filed 2026-08-12 | 67.76M shares 10-Q · filed 2026-08-12 | 65.35M shares derived: average of 3 quarters · filed 2026-08-12 | 64.15M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 63.22M shares 10-Q · filed 2026-05-12 | 61.90M shares derived: average of 2 quarters · filed 2026-05-12 | 61.46M shares derived: average of 3 quarters · filed 2026-05-12 | 61.24M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | 60.57M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 60.57M shares derived: average of 2 quarters · filed 2026-03-26 | 60.57M shares derived: average of 3 quarters · filed 2026-08-12 | 60.56M shares 10-K · filed 2026-03-26 |
| 2025-09-30 | 60.57M shares 10-Q · filed 2025-11-12 | 60.57M shares derived: average of 2 quarters · filed 2026-08-12 | 60.56M shares 10-Q · filed 2025-11-12 | 60.44M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | 60.57M shares 10-Q · filed 2026-08-12 | 60.55M shares 10-Q · filed 2026-08-12 | 60.39M shares derived: average of 3 quarters · filed 2026-08-12 | 60.31M shares derived: average of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | 60.53M shares 10-Q · filed 2026-05-12 | 60.30M shares derived: average of 2 quarters · filed 2026-05-12 | 60.23M shares derived: average of 3 quarters · filed 2026-05-12 | 60.19M shares derived: average of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | 60.08M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | 60.08M shares derived: average of 2 quarters · filed 2026-03-26 | 60.08M shares derived: average of 3 quarters · filed 2026-03-26 | 60.01M shares 10-K · filed 2026-03-26 |
| 2024-09-30 | 60.08M shares 10-Q · filed 2025-11-12 | 60.08M shares derived: average of 2 quarters · filed 2025-11-12 | 59.99M shares 10-Q · filed 2025-11-12 | 59.50M shares derived: average of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | 60.08M shares 10-Q · filed 2025-08-12 | 59.95M shares 10-Q · filed 2025-08-12 | 59.30M shares derived: average of 3 quarters · filed 2025-08-12 | 58.03M shares derived: average of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | 59.81M shares 10-Q · filed 2025-05-13 | 58.91M shares derived: average of 2 quarters · filed 2025-05-13 | 57.35M shares derived: average of 3 quarters · filed 2025-05-13 | 53.27M shares derived: average of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | 58.01M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | 56.12M shares derived: average of 2 quarters · filed 2025-03-27 | 51.09M shares derived: average of 3 quarters · filed 2025-03-27 | 48.61M shares 10-K · filed 2025-03-27 |
| 2023-09-30 | 54.23M shares 10-Q · filed 2024-11-12 | 47.63M shares derived: average of 2 quarters · filed 2024-11-12 | 45.47M shares 10-Q · filed 2024-11-12 | 44.30M shares derived: average of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | 41.03M shares 10-Q · filed 2024-08-13 | 41.03M shares 10-Q · filed 2024-08-13 | 40.99M shares derived: average of 3 quarters · filed 2024-08-13 | 40.87M shares derived: average of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | 41.03M shares 10-Q · filed 2024-05-14 | 40.98M shares derived: average of 2 quarters · filed 2024-05-14 | 40.82M shares derived: average of 3 quarters · filed 2024-05-14 | 40.74M shares derived: average of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | 40.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | 40.72M shares derived: average of 2 quarters · filed 2024-03-26 | 40.64M shares derived: average of 3 quarters · filed 2024-03-26 | 40.60M shares 10-K · filed 2024-03-26 |
| 2022-09-30 | 40.50M shares 10-Q · filed 2023-11-13 | 40.50M shares derived: average of 2 quarters · filed 2023-11-13 | 40.49M shares 10-Q · filed 2023-11-13 | 40.54M shares derived: average of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | 40.50M shares 10-Q · filed 2023-08-08 | 40.49M shares 10-Q · filed 2023-08-08 | 40.56M shares derived: average of 3 quarters · filed 2023-08-08 | 39.98M shares derived: average of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | 40.47M shares 10-Q · filed 2023-05-09 | 40.58M shares derived: average of 2 quarters · filed 2023-05-09 | 39.81M shares derived: average of 3 quarters · filed 2023-05-09 | 29.97M shares derived: average of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | 40.70M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | 39.48M shares derived: average of 2 quarters · filed 2023-03-27 | 26.47M shares derived: average of 3 quarters · filed 2023-03-27 | 20.06M shares 10-K · filed 2023-03-27 |
| 2021-09-30 | 38.27M shares 10-Q · filed 2022-11-14 | 19.35M shares derived: average of 2 quarters · filed 2022-11-14 | 13.18M shares 10-Q · filed 2022-11-14 | |
| 2021-06-30 | 432.32K shares 10-Q · filed 2022-08-15 | 425.76K shares 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |